The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer
Official Title: Phase I Trial to Compare Pharmacokinetics and Safety of Docetaxel PNP With Taxotere in Subjects With Advanced Solid Tumor
Study ID: NCT02274610
Brief Summary: Evaluation of the pharmacokinetic equivalence of two Docetaxel formulations in terms of AUC and Cmax
Detailed Description: Comparison of pharmacokinetic parameters (T1/2β, CL, Vdss) Safety as measured by adverse events
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Name: Mi-ryung Jin, Masters
Affiliation: Samyang Biopharmaceuticals Corporation
Role: STUDY_DIRECTOR